The cost of clinical trials in cancer.
Snyder Rd , Burns Wi
Australian Health Review 5 ( 2) 27
1982
The false negative mammogram.
Snyder Rd
Australian Family Physician 20 ( 6) 883
432
1991
Some aspects of the development of methotrexate therapy.
Snyder Rd
Clinical and Experimental Pharmacology 5 1 -4
3
1979
Clinical trials in cancer medicine.
Snyder Rd , Schwarz Ma
Australian Family Physician 9 ( 1) 23
6
1980
Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey.
BRENDA GRABSCH , DAVID M. CLARKE , ANTHONY LOVE , DEAN P. McKENZIE
Palliative & Supportive Care 4 ( 1) 47 -56
109
2006
COLORECTAL CANCER: THE MODERN TREATMENT OF DISSEMINATED DISEASE
RAYMOND D. SNYDER , W. IVON BURNS
Australian and New Zealand Journal of Surgery 51 ( 4) 377 -377
1981
Central nervous system metastases in women with HER‐2 positive metastatic breast cancer after treatment with trastuzumab
Sarah-Jane DAWSON , Nadia F RANIERI , Raymond D SNYDER , Sue-Anne McLACHLAN
Asia-pacific Journal of Clinical Oncology 2 ( 1) 50 -56
2
2006
Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2‐positive breast cancer
Raymond D SNYDER , Frances M BOYLE , Arlene CHAN , Paul S CRAFT
Asia-pacific Journal of Clinical Oncology 5 ( 1) 4 -16
2
2009
A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels.
Say Liang NG , William I BURNS , Raymond D SNYDER , Genni M NEWNHAM
Asia-pacific Journal of Clinical Oncology 8 ( 2) 172 -179
2
2012
Microwave adjuvant to radiotherapy and chemotherapy for advanced lymphoma
RD SNYDER , WI BURNS
MEDICAL JOURNAL OF AUSTRALIA 1 ( 11) 561 -561
1
1980
THE ROLE OF AUSTRALIAN REGULATORY AUTHORITIES IN THE DEVELOPMENT OF NEW ANTI-CANCER DRUGS
RD SNYDER
MEDICAL AND PEDIATRIC ONCOLOGY 11 ( 3) 192 -192
1983
DELAYED TOXICITY-IS IT THE PRICE OF EFFECTIVE CANCER-TREATMENT
RD SNYDER , WI BURNS
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 11 ( 3) 334 -334
1981
PROSPECTIVE NERVE-CONDUCTION STUDIES IN CISPLATIN THERAPY
JE RIGGS , M ASHRAF , RD SNYDER , L GUTMANN
ANNALS OF NEUROLOGY 22 ( 1) 166 -166
1987
Prognostic Factors in Pancreatic Cancer
Raymond David Snyder
University of Melbourne
1985
Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.
Lorenzo Gianni , Bernard F. Cole , Ilaria Panzini , Raymond Snyder
Supportive Care in Cancer 16 ( 1) 67 -74
11
2008
Dose intensity and outcome with combination chemotherapy for germ cell carcinoma
John A Levi , Damien Thomson , James Bishop , Derek Raghavan
European Journal of Cancer and Clinical Oncology 25 ( 7) 1073 -1077
5
1989
"cast adrift": The experience of completing treatment among women with early stage breast cancer
Carrie E. Lethborg , David Kissane , W. Ivon Burns , Raymond Snyder
Journal of Psychosocial Oncology 18 ( 4) 73 -90
58
2000
Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience
Karen Price , Aron Goldhirsch , Marco Colleoni , David Zahrieh
Journal of Clinical Oncology 23 ( 7) 1390 -1400
70
2005
Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials
Bernhard C. Pestalozzi , David Zahrieh , Elizabeth Mallon , Barry A. Gusterson
Journal of Clinical Oncology 26 ( 18) 3006 -3014
266
2008
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.
David M. Hyams , Arlene Chan , Celia de Oliveira , Raymond Snyder
Investigational New Drugs 31 ( 5) 1345 -1354
29
2013